COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,456,545 | -41.7% | 1,246,977 | -5.8% | 3.92% | +27.4% |
| Q2 2023 | $4,210,546 | -63.0% | 1,324,071 | -62.0% | 3.08% | -63.4% |
| Q1 2023 | $11,381,964 | -48.6% | 3,480,723 | -20.9% | 8.41% | -51.1% |
| Q4 2022 | $22,132,000 | +120.6% | 4,400,000 | 0.0% | 17.19% | +122.8% |
| Q3 2022 | $10,032,000 | -14.0% | 4,400,000 | 0.0% | 7.71% | -5.3% |
| Q2 2022 | $11,660,000 | +93.4% | 4,400,000 | 0.0% | 8.15% | +230.9% |
| Q1 2022 | $6,028,000 | -56.8% | 4,400,000 | 0.0% | 2.46% | -28.2% |
| Q4 2021 | $13,948,000 | – | 4,400,000 | – | 3.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,246,977 | $2,456,545 | 3.92% |
| CHI Advisors LLC | 2,829,712 | $5,574,532 | 2.21% |
| Ally Bridge Group (NY) LLC | 914,630 | $1,801,821 | 2.12% |
| Monashee Investment Management LLC | 1,226,142 | $2,415,500 | 1.01% |
| Orbimed Advisors | 22,362,850 | $44,054,815 | 0.94% |
| Vivo Capital, LLC | 3,556,023 | $7,005,365 | 0.77% |
| CAXTON CORP | 86,773 | $170,942 | 0.65% |
| Prosight Management, LP | 935,157 | $1,842,259 | 0.58% |
| BRAIDWELL LP | 5,954,273 | $11,729,918 | 0.37% |
| Rock Springs Capital Management LP | 5,513,788 | $10,862,162 | 0.29% |